Role of CYP2C19 pharmacogenetic polymorphism on response of esomeprazole in the treatment of GERD

被引：0
作者：
Halimi, Shafarul
Abu Hassan, Muhammad Radzi
Ismail, Rusli
Kiew, Kuang Kiat
Zainuddin, Zalwani
Mustapha, Mohd Nazri
Mokhtar, Suraya
机构：
[1] Univ Sains Malaysia, George Town, Malaysia
[2] Hosp Univ Sains Malaysia, George Town, Malaysia
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2013年 / 28卷
关键词：
pharmacogenetics; polymorphism; GERD;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：67 / 68
页数：2
相关论文
共 50 条
  • [31] Relationship of CYP2C19*2 and CYP2C19*3 Gene Polymorphism with Clopidogrel Response Variability and Recurrent Cardiovascular Events in Chinese Patients Undergoing Percutaneous Coronary Intervention
    Liu, Yamin
    Liu, Naifeng
    Li, Weilan
    Shao, Hua
    Zhi, Hong
    Li, Jie
    PHARMACOLOGY, 2013, 91 (3-4) : 165 - 172
  • [32] Genetic polymorphism of CYP2C19 and lansoprazole pharmacokinetics in Japanese subjects
    H. Katsuki
    C. Nakamura
    K. Arimori
    S. Fujiyama
    M. Nakano
    European Journal of Clinical Pharmacology, 1997, 52 : 391 - 396
  • [33] Genetic polymorphism of CYP2C19 and lansoprazole pharmacokinetics in Japanese subjects
    Katsuki, H
    Nakamura, C
    Arimori, K
    Fujiyama, S
    Nakano, M
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 52 (05) : 391 - 396
  • [34] Assessment of CYP2C19 genetic polymorphisms in a korean population using a simultaneous multiplex pyrosequencing method to simultaneously detect the CYP2C19*2, CYP2C19*3, and CYP2C19*17 alleles
    Kim, K. -A.
    Song, W. -K.
    Kim, K. -R.
    Park, J. -Y.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2010, 35 (06) : 697 - 703
  • [35] Evaluation of CYP2C19 Gene Polymorphisms in Patients with Acid Peptic Disorders Treated with Esomeprazole
    Diaz-Ordonez, Lorena
    Ramirez-Montano, Diana
    Candelo, Estephania
    Gonzalez-Restrepo, Carolina
    Silva-Pena, Sebastian
    Arturo Rojas, Carlos
    Sepulveda Copete, Mario
    Raul Echavarria, Hector
    Pachajoa, Harry
    PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2021, 14 : 509 - 520
  • [36] Polymorphism of CYP2D6, CYP2C19, CYP2C9 and CYP2C8 in the Faroese population
    Jónrit Halling
    Maria S. Petersen
    Per Damkier
    Flemming Nielsen
    Philippe Grandjean
    Pál Weihe
    Stefan Lundgren
    Mia Sandberg Lundblad
    Kim Brøsen
    European Journal of Clinical Pharmacology, 2005, 61 : 491 - 497
  • [37] Association of MDR1, CYP2D6, and CYP2C19 gene polymorphisms with prophylactic migraine treatment response
    Atasayar, Gulfer
    Eryilmaz, Isil Ezgi
    Karli, Necdet
    Egeli, Unal
    Zarifoglu, Mehmet
    Cecener, Gulsah
    Taskapilioglu, Ozlern
    Tunca, Berrin
    Yildirim, Oznur
    Ak, Secil
    Tezcan, Gulcin
    Can, Fatma Ezgi
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2016, 366 : 149 - 154
  • [38] Role of CYP2C19 gene polymorphism in acute alcohol withdrawal treatment with loading dose of diazepam in a South Indian population
    Manu Jose
    Jayanthi Mathaiyan
    Shivanand Kattimani
    Surendiran Adithan
    Adithan Chandrasekaran
    European Journal of Clinical Pharmacology, 2016, 72 : 807 - 812
  • [39] Implementation and management outcomes of pharmacogenetic CYP2C19 testing for clopidogrel therapy in clinical practice
    Stefan Russmann
    Ali Rahmany
    David Niedrig
    Karl-Dietrich Hatz
    Katja Ludin
    Andrea M. Burden
    Lars Englberger
    Roland Backhaus
    Andreas Serra
    Markus Béchir
    European Journal of Clinical Pharmacology, 2021, 77 : 709 - 716
  • [40] Role of CYP2C19 gene polymorphism in acute alcohol withdrawal treatment with loading dose of diazepam in a South Indian population
    Jose, Manu
    Mathaiyan, Jayanthi
    Kattimani, Shivanand
    Adithan, Surendiran
    Chandrasekaran, Adithan
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 72 (07) : 807 - 812
12345